ProfileGDS4718 / 1560565_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 8% 13% 7% 15% 8% 13% 12% 9% 11% 9% 13% 12% 16% 15% 12% 10% 12% 15% 12% 14% 12% 12% 10% 9% 9% 15% 9% 8% 15% 19% 12% 14% 11% 13% 13% 10% 18% 11% 15% 8% 14% 14% 17% 16% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]3.723798
GSM549102patient 115, normal, homogenized [OPG study]3.9030613
GSM549104patient 119, normal, homogenized [OPG study]3.659837
GSM549108patient 138, normal, homogenized [OPG study]3.9892515
GSM549119patient 077, normal, homogenized [OPG study]3.69298
GSM549133patient 032, cancer, homogenized [OPG study]3.8558713
GSM549139patient 042, cancer, homogenized [OPG study]3.827412
GSM549099patient 107, normal, homogenized [OPG study]3.763739
GSM549109patient 139, normal, homogenized [OPG study]3.8315311
GSM549110patient 046, normal, homogenized [OPG study]3.75669
GSM549114patient 063, normal, homogenized [OPG study]3.8657313
GSM549122patient 082, normal, homogenized [OPG study]3.863912
GSM549134patient 033, cancer, homogenized [OPG study]3.9842916
GSM549136patient 036, cancer, homogenized [OPG study]3.9287915
GSM549140patient 044, cancer, homogenized [OPG study]3.8392312
GSM549111patient 047, normal, homogenized [OPG study]3.7530410
GSM549113patient 057, normal, homogenized [OPG study]3.8289112
GSM549132patient 031, cancer, homogenized [OPG study]3.9627515
GSM549137patient 038, cancer, homogenized [OPG study]3.846612
GSM549142patient 047, cancer, homogenized [OPG study]3.9906814
GSM549100patient 110, normal, homogenized [OPG study]3.873312
GSM549107patient 135, normal, homogenized [OPG study]3.8337612
GSM549115patient 068, normal, homogenized [OPG study]3.7635110
GSM549116patient 072, normal, homogenized [OPG study]3.729899
GSM549120patient 078, normal, homogenized [OPG study]3.733059
GSM549131patient 030, cancer, homogenized [OPG study]3.914415
GSM549118patient 074, normal, homogenized [OPG study]3.759
GSM549129patient 027, cancer, homogenized [OPG study]3.715888
GSM549123patient 088, normal, homogenized [OPG study]3.9581515
GSM549124patient 006, cancer, homogenized [OPG study]4.1654219
GSM549126patient 015, cancer, homogenized [OPG study]3.8339112
GSM549128patient 025, cancer, homogenized [OPG study]3.914414
GSM549103patient 117, normal, homogenized [OPG study]3.8544111
GSM549117patient 073, normal, homogenized [OPG study]3.8731213
GSM549138patient 041, cancer, homogenized [OPG study]3.8814413
GSM549141patient 045, cancer, homogenized [OPG study]3.7254410
GSM549130patient 028, cancer, homogenized [OPG study]4.0774418
GSM549101patient 111, normal, homogenized [OPG study]3.8111111
GSM549105patient 128, normal, homogenized [OPG study]3.9812215
GSM549106patient 134, normal, homogenized [OPG study]3.667478
GSM549112patient 048, normal, homogenized [OPG study]3.9016614
GSM549125patient 011, cancer, homogenized [OPG study]3.9342914
GSM549127patient 024, cancer, homogenized [OPG study]4.0215217
GSM549135patient 035, cancer, homogenized [OPG study]3.9539616